{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:17:10Z","timestamp":1789067830957,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.vaccine.2012.12.063","type":"journal-article","created":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T17:01:54Z","timestamp":1357578114000},"page":"1163-1170","source":"Crossref","is-referenced-by-count":54,"title":["Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA\/I overexpressing bacteria and recombinantly produced LTB\/CTB hybrid protein"],"prefix":"10.1016","volume":"31","author":[{"given":"A.","family":"Lundgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Carlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jertborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.","family":"Svennerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.12.063_bib0005","unstructured":"World Health Organization. Diarrhoeal diseases. http:\/\/www.who.int\/vaccine_research\/diseases\/diarrhoeal\/en\/index4.html [consulted October 2012]."},{"issue":"3","key":"10.1016\/j.vaccine.2012.12.063_bib0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.18.3.465-483.2005","article-title":"Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention","volume":"18","author":"Qadri","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"14","key":"10.1016\/j.vaccine.2012.12.063_bib0015","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.vaccine.2006.12.028","article-title":"Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease","volume":"25","author":"Walker","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.12.063_bib0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1586\/erv.12.12","article-title":"Recent progress toward an enterotoxigenic Escherichia coli vaccine","volume":"11","author":"Svennerholm","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2012.12.063_bib0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0264-410X(97)00169-2","article-title":"Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine","volume":"16","author":"Jertborn","year":"1998","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.12.063_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1586\/14760584.7.6.795","article-title":"Vaccines against enterotoxigenic Escherichia coli","volume":"7","author":"Svennerholm","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2012.12.063_bib0035","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1128\/IAI.66.7.3311-3316.1998","article-title":"Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood","volume":"66","author":"Ahren","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2012.12.063_bib0040","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1128\/CDLI.8.2.424-428.2001","article-title":"Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine","volume":"8","author":"Jertborn","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.12.063_bib0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/314543","article-title":"Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group","volume":"179","author":"Savarino","year":"1999","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2012.12.063_bib0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00006454-200204000-00012","article-title":"Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants","volume":"21","author":"Savarino","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2012.12.063_bib0055","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/S0264-410X(03)00077-X","article-title":"Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18\u201336 months of age","volume":"21","author":"Qadri","year":"2003","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2012.12.063_bib0060","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.vaccine.2005.08.110","article-title":"Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6\u201317 months of age: dosing studies in different age groups","volume":"24","author":"Qadri","year":"2006","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2012.12.063_bib0065","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1016\/j.vaccine.2007.03.034","article-title":"Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico","volume":"25","author":"Sack","year":"2007","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2012.12.063_bib0070","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1016\/j.vaccine.2011.06.084","article-title":"A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression","volume":"29","author":"Isidean","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.12.063_bib0075","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1128\/IAI.64.6.2144-2150.1996","article-title":"Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine","volume":"64","author":"Lebens","year":"1996","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2012.12.063_bib0080","first-page":"188","article-title":"From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development","volume":"133","author":"Svennerholm","year":"2011","journal-title":"Indian J Med Res"},{"issue":"6","key":"10.1016\/j.vaccine.2012.12.063_bib0085","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00253-012-3930-6","article-title":"Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates","volume":"93","author":"Tobias","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2012.12.063_bib0090","unstructured":"Holmgren J, Blomquist M, Bourgeois L, Carlin N, Clements J, Ekman A, et al. Preclinical evaluation of an oral inactivated ETEC vaccine, based on E. coli overexpressing CFA\/I, CS3, CS5, and CS6 together with LTB\/CTB subunit, and of the adjuvant effect of co-administration with dmLT. Vaccines for enteric diseases 2011; Cannes, France."},{"issue":"6","key":"10.1016\/j.vaccine.2012.12.063_bib0095","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.vaccine.2007.12.009","article-title":"Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae","volume":"26","author":"Tobias","year":"2008","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2012.12.063_bib0100","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1016\/j.vaccine.2010.08.047","article-title":"Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria","volume":"28","author":"Tobias","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.12.063_bib0105","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/infdis\/152.6.1128","article-title":"Presence of colonization factor antigens on fresh isolates of fecal Escherichia coli: a prospective study","volume":"152","author":"Gothefors","year":"1985","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2012.12.063_bib0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1073\/pnas.86.2.481","article-title":"Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development","volume":"86","author":"Sanchez","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"33","key":"10.1016\/j.vaccine.2012.12.063_bib0115","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1016\/j.vaccine.2009.05.005","article-title":"Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methods","volume":"27","author":"Lundgren","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2012.12.063_bib0120","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1128\/IAI.67.12.6234-6241.1999","article-title":"Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees","volume":"67","author":"Wenneras","year":"1999","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2012.12.063_bib0125","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/CVI.05342-11","article-title":"A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and LTB is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults","volume":"18","author":"Harro","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2012.12.063_bib0130","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1016\/j.vaccine.2005.07.022","article-title":"Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers","volume":"24","author":"Carpenter","year":"2006","journal-title":"Vaccine"},{"issue":"8778","key":"10.1016\/j.vaccine.2012.12.063_bib0135","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0140-6736(91)92590-X","article-title":"Prevention of travellers\u2019 diarrhoea by oral B-subunit\/whole-cell cholera vaccine","volume":"338","author":"Peltola","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2012.12.063_bib0140","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2012.12.063_bib0145","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1128\/IAI.00459-07","article-title":"Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh","volume":"75","author":"Qadri","year":"2007","journal-title":"Infect Immun"},{"issue":"8267","key":"10.1016\/j.vaccine.2012.12.063_bib0150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(82)91568-9","article-title":"Intestinal antibody responses after immunisation with cholera B subunit","volume":"1","author":"Svennerholm","year":"1982","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2012.12.063_bib0155","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/CVI.00538-10","article-title":"Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G\/L211A), as a safe and effective oral adjuvant","volume":"18","author":"Norton","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"48","key":"10.1016\/j.vaccine.2012.12.063_bib0160","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.1016\/j.vaccine.2011.09.096","article-title":"Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice","volume":"29","author":"Tobias","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:49:17Z","timestamp":1595206157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12018506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0264410X12018506"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}